基本信息
文件名称:NLRP3-IN-69-生命科学试剂-MCE.pdf
文件大小:455.95 KB
总页数:1 页
更新时间:2025-03-19
总字数:约2.04千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

NLRP3-IN-69

Cat.No.:HY-170836

CASNo.:3027608-60-9

分?式:C??H??O?

分?量:436.45

作?靶点:NOD-likeReceptor(NLR);NF-κB;NOSynthase;COX;

InterleukinRelated

作?通路:Immunology/Inflammation;NF-κB

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性NLRP3-IN-69(Compound23)抑制NF-κBp65的激活和NLRP3炎症?体的形成。NLRP3-IN-69抑制LPS

(HY-D1056)诱导的IL-1β、iNOS和COX-2的过度表达,抑制NO的?成(IC50=5.66μM),从?表现出抗

炎活性[1]。

REFERENCES

[1].YuJ,etal.,NovelCinnamicAcidDerivativesContainingNaproxenasNLRP3Inhibitors:SynthesisandEvaluationofTheirBiological

Activity.ChemBiodivers.2024Dec29:e202402700.

McePdfHeight

Caution:Producthasnotbeenfullyvalidatedformedicalapplications.

Forresearchuseonly.

Tel:400-820-3792;021Fax:021E-mail:tech@MedChemE

1/1MasterofBioact